Farms.com Home   News

AAFC Prairie Biovigilance Network (PBN) needs help from farmers

The Agriculture and Agri-Food Canada Prairie Biovigilance Network (PBN) group was developed to address concerns related to surveying of wheat diseases in the Prairie region as well as general insect and weed issues. Access to wheat samples is critical for the work group conducts. 

The group needs farmer assistance with a leaf disease survey of commercial wheat fields, and a survey of stored product insects occurring in farm grain bins, in the Prairie region. The goal of these surveys is to create additional awareness regarding the prevalence, variability and impact of leaf diseases and stored grain product insects across the Prairies.  In addition, data summaries and recommendations will be sent back to collaborating producers to inform them of the diseases and pests present and how their levels compare with other Prairie producers over a range of production practices.  

All information identifying specific producers and locations will remain strictly confidential.  During the winter of 2022, collaborating farmers will be sent the results from their samples as well as a summary of results based on region and cropping practices. In addition, an overall summary of the survey will be published in the Canadian Plant Disease Survey as well as the annual Western Committee on Plant Disease annual disease situation report.

Farmers will be sent a package comprised of sampling kits and instructions for wheat leaf collections as well as stored-grain insects collections. Pre-paid envelopes to return the leaf samples and the stored insect pests will be provided. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.